Teva Pharmaceutical Industries (TEVA) EBT Margin (2016 - 2026)
Teva Pharmaceutical Industries (TEVA) recorded quarterly EBT Margin of 10.97% in Q1 2026, up 546.25% on a QoQ basis from 1.7% in Q4 2025, and up 342.0% year-over-year from 2.48% in Q1 2025.
Teva Pharmaceutical Industries (TEVA) EBT Margin (2016 - 2026) Analysis & Trends
Teva Pharmaceutical Industries has disclosed EBT Margin across 11 years of filings, most recently posting 10.97% for Q1 2026.
- Quarterly EBT Margin rose 342.0% year-over-year to 10.97% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.87% (up 1129.0% YoY) and the FY2025 annual result came in at 7.09%, up 1485.0% from the prior year.
- EBT Margin grew to 10.97% in Q1 2026, from 1.7% in the prior quarter.
- Over five years, EBT Margin peaked at 14.42% in Q3 2025 and troughed at 31.11% in Q2 2022.
- A 5-year average of 4.22% and a median of 1.66% in 2023 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin tumbled 3899 bps — and 2023, when it surged 4189 bps.
- Tracing TEVA's EBT Margin over 5 years: stood at 30.51% in 2022, then jumped by 137 bps to 11.38% in 2023, then plunged by 175 bps to 8.52% in 2024, then jumped by 120 bps to 1.7% in 2025, then jumped by 546 bps to 10.97% in 2026.
- Business Quant data shows TEVA's EBT Margin at 10.97% in Q1 2026, 1.7% in Q4 2025, and 14.42% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -156.77% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 41.45% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.70% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 42.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.97% |
| Dec 31, 2025 | 1.70% |
| Sep 30, 2025 | 14.42% |
| Jun 30, 2025 | 4.86% |
| Mar 31, 2025 | 7.56% |
| Dec 31, 2024 | -8.52% |
| Sep 30, 2024 | -7.48% |
| Jun 30, 2024 | -5.91% |
| Mar 31, 2024 | 12.23% |
| Dec 31, 2023 | 11.38% |
| Sep 30, 2023 | 1.66% |
| Jun 30, 2023 | -23.80% |
| Mar 31, 2023 | -7.43% |
| Dec 31, 2022 | -30.51% |
| Sep 30, 2022 | 4.76% |
| Jun 30, 2022 | -31.11% |
| Mar 31, 2022 | -26.52% |
| Dec 31, 2021 | -4.27% |
| Sep 30, 2021 | 9.83% |
| Jun 30, 2021 | 7.88% |